

Is Benicar in shortage in 2026? Get the latest update on Olmesartan availability, pricing, and what to do if you can't find your prescription.
If you've had trouble filling your Benicar (Olmesartan Medoxomil) prescription recently, you're not imagining things. While Olmesartan is not on the FDA's official drug shortage list as a standalone medication, patients across the country have reported availability issues at their local pharmacies.
Here's everything you need to know about the current Benicar supply situation in 2026 — and what you can do about it.
The short answer: it's complicated. Here's the breakdown:
So while Olmesartan itself is not formally in shortage, many patients are experiencing localized availability issues depending on which product they take and which pharmacy they use.
Several factors contribute to the current availability challenges:
The generic drug market has seen significant consolidation in recent years. Fewer manufacturers producing Olmesartan products means that when one company has a production issue or discontinues a product, the impact is felt more broadly.
Drug wholesalers sometimes put medications on allocation, meaning pharmacies can only order limited quantities. This is especially common when demand temporarily outpaces supply. If your pharmacy hits its allocation limit, they may not be able to fill your prescription even though the drug isn't technically in shortage.
Insurance companies regularly update their preferred drug lists. If major insurers shift toward other ARBs like Losartan (which is typically cheaper), pharmacies may reduce their Olmesartan inventory, making it harder to find on the shelf.
Ongoing global supply chain challenges — from raw material sourcing to manufacturing delays to shipping disruptions — continue to affect the pharmaceutical industry broadly. Blood pressure medications like Olmesartan are not immune to these pressures.
Understanding the cost landscape can help you make informed decisions:
For a full breakdown of savings options, read our guide: How to Save Money on Benicar in 2026: Coupons, Discounts, and Patient Assistance.
If you're struggling with availability or cost, there are several newer paths to consider:
Online and mail-order pharmacies like Amazon Pharmacy and Cost Plus Drugs often have better inventory than local retail pharmacies. A 90-day supply is usually more convenient and cheaper than monthly fills.
If you can't find your specific Olmesartan combination product, ask your doctor about taking the components separately. For example, instead of Benicar HCT (Olmesartan + Hydrochlorothiazide), you could take generic Olmesartan and generic Hydrochlorothiazide as two separate pills. This gives you more flexibility in sourcing each medication.
If Olmesartan is truly unavailable in your area, other ARBs like Losartan, Valsartan, Irbesartan, and Telmisartan are all effective alternatives. Read our detailed comparison: Alternatives to Benicar If You Can't Fill Your Prescription.
Here are the fastest ways to locate Olmesartan:
For a complete playbook, read: How to Find Benicar in Stock Near You (Tools + Tips).
The Benicar supply situation in 2026 is manageable — generic Olmesartan is not in a widespread national shortage, but localized issues are real. The combination products have been hit harder by manufacturer discontinuations.
The most important thing is to not stop taking your blood pressure medication. High blood pressure often has no symptoms, but it significantly increases your risk of heart attack, stroke, and kidney disease. If you can't find your specific medication, work with your doctor to find an alternative that keeps you protected.
Use Medfinder to check real-time stock near you, and explore our other Benicar resources:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.